Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Satellos Bioscience Inc. Capital/Financing Update 2026

Feb 6, 2026

48203_rns_2026-02-06_a9c0f173-6eae-4e05-b946-7bd42cc5a064.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

{0}------------------------------------------------

February 5, 2026 By SEDAR+

To: Ontario Securities Commission, as Principal Regulator under the

Passport System

And to: Alberta Securities Commission

British Columbia Securities Commission

Dear Sirs/Mesdames:

Re: Prospectus Supplement dated February 5, 2026 to the Short Form Base Shelf Prospectus dated October 29, 2025 (the "Supplement")

We refer you to the Supplement relating to the offering of common shares and pre-funded warrants of Satellos Bioscience Inc.

We consent to being named on the inside cover page of the Supplement and under the heading "Legal Matters & Interests of Experts" in the Supplement, and consent to the use of our legal opinions set out under the headings "Certain Canadian Federal Income Tax Considerations" and "Eligibility for Investment", which opinions are provided as of the date of the Supplement.

We have read the Supplement and have no reason to believe that there are any misrepresentations in the information contained in the Supplement that are (i) derived from our legal opinions provided in the Supplement, or (ii) within our knowledge as a result of the services performed by us in connection with such opinions.

Yours truly,

(signed) "Stikeman Elliott LLP"